Patients with or without a clonal mast cell disease undergoing venom immunotherapy differ in their CD8 T memory cell response.
Saved in:
| Title: | Patients with or without a clonal mast cell disease undergoing venom immunotherapy differ in their CD8 T memory cell response. |
|---|---|
| Authors: | Teufelberger AR; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Electronic address: andrea.teufelberger@medunigraz.at., Cerpes U; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Dan AR; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Bokanovic D; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Fink-Puches R; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Mahnke NA; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Vera Ayala C; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Chu Wang SY; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Pyatilova P; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Fedai K; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Frischbutter S; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Fessler J; Department of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria., Siebenhaar F; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Kränke B; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Wolf P; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. |
| Source: | The Journal of investigative dermatology [J Invest Dermatol] 2026 May 05. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
